Head to head
Elevance Health vs UnitedHealth
Side-by-side on the measures that matter, with a plain-English read. Full detail: ELV · UNH
ELV
Elevance Health
413.75+0.04%
1-year price shape — +35% over the period
Quant Rating B · 70/100
vs
UNH
UnitedHealth
404.44+1.00%
1-year price shape — +24% over the period
Quant Rating C · 57/100
1-year performance, rebased to 100
UnitedHealth edges it on the scoreable measures. UnitedHealth pays the highest dividend yield.
| ELV | UNH | |
|---|---|---|
| Snapshot | ||
| Sector | Healthcare Plans | Healthcare Plans |
| Last price | 413.75 | 404.44 |
| Change today | +0.04% | +1.00% |
| 1-year return | +34.7% | +23.6% |
| Market cap | $89.39B | $362.39B |
| 52-week range | 270.87 – 450.69 | 252.95 – 458.79 |
| Valuation | ||
| P/E (TTM) | 17.57 | 23.08 |
| P/E percentile, own 5-yr range | 55th | 40th |
| P/B | 2.00 | 3.69 |
| Dividend yield | 1.66% | 2.24% |
| Profitability & growth | ||
| EPS (TTM) | 25.21 | 13.23 |
| Net profit (TTM) | $5.45B | $11.85B |
| Revenue (TTM) | $201.83B | $449.66B |
| Revenue growth (YoY) | +1.4% | -0.4% |
| Gross margin | -- | 19.8% |
| Operating margin | -- | 5.3% |
| Net margin | 2.5% | 3.5% |
| Free cash flow (TTM) | $6.51B | $22.83B |
| Ownership & sentiment | ||
| Institutional ownership | 95.7% | 89.0% |
| Insider activity (12mo) | 31 buy / 19 sell | 46 buy / 4 sell |
| Short interest (% of float) | 2.4% | 1.6% |
| Analyst consensus | 69% buy / 31% hold (13) | 78% buy / 22% hold (18) |
| Analyst price target | $482 (+16%) | $485 (+20%) |
| StockVane view | ||
| StockVane Quant Rating | B (70) | C (57) |
| Company | ||
| Employees | 97,100 | 390,000 |
| Founded | 1944 | -- |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.